GoldenGolden
Advanced Search

Inhibrx

Inhibrx is an antibodies, Fusion Proteins.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

Funding rounds

SBA Awards

Patents

Products

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Inhibrx, Inc.
June 21, 2021
www.prnewswire.com:443
/PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development, announced initiation of a potential...
Inhibrx, Inc.
February 1, 2021
www.prnewswire.com:443
/PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX), a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic...
Inhibrx, Inc.
November 13, 2020
www.prnewswire.com:443
/PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development, today reported financial results for the...
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.